System harnesses waste heat to produce enough drinkable water for an adult in 1 h

Good yields and enantioselectivity abide

Probiotics, sensors, and MOFs are among technologies that could keep herds healthy as industry turns away from antibiotics

Cement, ethanol, and ammonia makers are among those looking to convert waste carbon to cash

C&EN's editors pick the speakers and symposia to catch

Activists say contracts with companies violate federal law

Venture will combine six active pharmaceutical ingredient production sites in Europe

Facilities are reopening in China but spread of virus outside China is raising concerns

Experts praise the approach while remaining skeptical that the highlighted molecules could reach the clinic

Lower-temperature process improves the efficiency of single-crystal solar cells

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine

Detaching particles from the electrode surface frees them from electrical fatigue

Industry watchers say the effort is unprecedented and would not have been possible during the last SARS outbreak

Colibactin causes key cancer mutations

Biogen will pay the biotech firm $350 million upfront and get rights to its therapies for up to 12 neurological diseases

First Be(I) compounds to be crystallized could open up new main group chemistry

Multiple catalysts do complex chemistry to give a simple product

Activists say contracts with companies violate federal law

Lower-temperature process improves the efficiency of single-crystal solar cells

Single-crystal boron nitride could enable the use of 2-D materials for transistors in computer chips

USDA delays some requirements for growers, FDA seeks more data on cannabidiol products

Congress opts for open-ended support for federal and local agencies

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine

Experts praise the approach while remaining skeptical that the highlighted molecules could reach the clinic

Colibactin causes key cancer mutations

Venture will combine 6 active pharmaceutical ingredient production sites in Europe

Electrodes made from pantyhose are the basis of light-emitting fabrics that can stretch and change display patterns

First Be(I) compounds to be crystallized could open up new main-group chemistry

Method provides petroleum-free way to turn industrial biowaste into valuable commodity

160-million-atom simulation reveals potential drug targets

Her company, MicroByre, is proving that wild microbes can be engineered to produce useful chemicals

With Prieto Battery, the Colorado State professor has redesigned the lithium-ion battery from the bottom up

Her company, Biobot Analytics, is analyzing wastewater to give communities the information they need for the battle

Her company, Esya Labs, is developing DNA nanodevices that track drug responses, screen for new therapies, and more

Nanotech pioneer aims to pursue grand challenges rather than just write about them

With guest editor Jennifer Doudna, CRISPR pioneer

Gilead toma ventaja gracias a un antiviral, mientras que Moderna está buscando una nueva vacuna ARNm.

Concerns over the spread of the novel coronavirus leads to decision

Spring lineup of conferences and events frequented by chemists is slashed

Creating more opportunities for dialogue is just the first step

Complaint alleges trade secret theft, patent infringement on separator films

The technique, called MicroMapping, identifies potential protein interactions on and between cells

Microbe-specific tracers could help detect infection without relying on inflammation as a surrogate

Untargeted capture and analysis turns up previously unobserved airborne PFAS

Agency's approach for assessing risks to endangered species relies on real-world data